Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice

Carcinogenesis

Volumn 32, Issue 6, 2011, Pages 829-835

  Oghamian, Shirley ^a   Sodir, Nicole M ^a,c   Bashir, Muhammad U ^a   Shen, Hui ^b   Cullins, Andrea E ^a   Carroll, Cindy A ^a   Kundu, Pratima ^a   Shibata, Darryl ^a   Laird, Peter W ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC; DNA METHYLTRANSFERASE 1; PROTEIN P53;

ACINAR CELL CARCINOMA; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STAGING; CARCINOGENESIS; DNA METHYLATION; ENZYME BLOOD LEVEL; FEMALE; GENE MUTATION; IN VIVO STUDY; MALE; MOUSE; MULTIPLE CANCER; NONHUMAN; PRIORITY JOURNAL; PROGENY; TUMOR VOLUME;

EID: 79958221485     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr039     Document Type: Article

References (58)

1. Sato, N. (2002) Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology, 123, 365-372.
2. Sato, N. et al. (2005) Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene, 24, 850-858.
3. Sato, N. et al. (2008) CpG island methylation profile of pancreatic intraepithelial neoplasia. Mod. Pathol., 21, 238-244.
4. Fukushima, N. et al. (2002) Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am. J. Pathol., 160, 1573-1581.
5. Fukushima, N. et al. (2003) Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms. Br. J. Cancer., 89, 338-343.
6. Eads, C.A. et al. (2002) Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic Mice. Cancer Res., 62, 1296-1299.
7. Laird, P.W. et al. (1995) Suppression of intestinal neoplasia by DNA hypomethylation. Cell, 81, 197-205.
8. Trinh, B.N. et al. (2002) DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair. Mol. Cell. Biol., 22, 2906-2917.
9. Cormier, R.T. et al. (2000) Dnmt1N/+ reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/6-multiple intestinal neoplasia (Min)/+ mice independently of p53 but demonstrates strong synergy with the modifier of Min 1(AKR) resistance allele. Cancer Res., 60, 3965-3970.
10. MacLeod, A.R. et al. (1995) Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J. Biol. Chem., 270, 8037-8043.
11. Ramchandani, S. et al. (1997) Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc. Natl Acad. Sci. USA., 94, 684-689.
12. Yamada, Y. et al. (2005) Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl Acad. Sci. USA., 102, 13580-13585.
13. Eden, A. et al. (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science, 300, 455.
14. Baba, S. et al. (2009) Global DNA hypomethylation suppresses squamous carcinogenesis in the tongue and esophagus. Cancer Sci., 100, 1186-1191.
15. Moser, A.R. et al. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322-324.
16. Ichii, S. et al. (1992) Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP). Hum. Mol. Genet., 1, 387-390.
17. Li, E. et al. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell, 69, 915-926.
18. Jacks, T. et al. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4, 1-7.
19. Clarke, A.R. et al. (1995) Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. Oncogene, 11, 1913-1920.
20. Laird, P.W. et al. (1991) Simplified mammalian DNA isolation procedure. Nucleic Acids Res., 19, 4293.
21. Sodir, N.M. et al. (2006) Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice. Cancer Res., 66, 8430-8438.
22. Luongo, C. et al. (1994) Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res., 54, 5947-5952.
23. Gaudet, F. et al. (2003) Induction of tumors in mice by genomic hypomethylation. Science, 300, 489-492.
24. Linhart, H.G. et al. (2007) Dnmt3b promotes tumorigenesis in vivo by genespecific de novo methylation and transcriptional silencing. Genes Dev., 21, 3110-3122.
25. Tucker, K.L. et al. (1996) Germ-line passage is required for establishment of methylation and expression patterns of imprinted but not of nonimprinted genes. Genes Dev., 10, 1008-1020.
26. Lei, H. et al. (1996) De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development, 122, 3195-3205.
27. Shoemaker, A.R. et al. (1998) A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice. Proc. Natl Acad. Sci. USA., 95, 10826-10831.
28. Cecconi, D. et al. (2009) Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. Proteomics, 9, 1952-1966.
29. Kanda, T. et al. (2005) 5-aza-2'-deoxycytidine sensitizes hepatoma and pancreatic cancer cell lines. Oncol. Rep., 14, 975-979.
30. Peng, D.F. et al. (2005) Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci., 96, 403-408.
31. Peng, D.F. et al. (2006) DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. Carcinogenesis, 27, 1160-1168.
32. Fontaniere, S. et al. (2006) Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis. Endocr. Relat. Cancer., 13, 1223-1236.
33. Dejeux, E. et al. (2009) Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression. Endocr. Relat. Cancer., 16, 939-952.
34. Denicola, G. et al. (2005) VAV1: a new target in pancreatic cancer? Cancer Biol. Ther., 4, 509-511.
35. Fernandez-Zapico, M.E. et al. (2005) Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell, 7, 39-49.
36. Yoon, N.K. et al. (2010) Higher levels of GATA3 predict better survival in women with breast cancer. Hum. Pathol., 41, 1794-1801.
37. Dydensborg, A.B. et al. (2009) GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis. Oncogene, 28, 2634-2642.
38. Ting, C.N. et al. (1996) Transcription factor GATA-3 is required for development of the T-cell lineage. Nature, 384, 474-478.
39. Gulbinas, A. et al. (2006) Aberrant gata-3 expression in human pancreatic cancer. J. Histochem. Cytochem., 54, 161-169.
40. Teodoridis, J.M. et al. (2005) CpG island methylation of DNA damage response genes in advanced ovarian cancer. Cancer Res., 65, 8961-8967.
41. Mei, F.C. et al. (2006) RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells. FASEB J., 20, 497-499.
42. Czekierdowski, A. et al. (2006) Opioid-binding protein/cell adhesion molecule-like (OPCML) gene and promoter methylation status in women with ovarian cancer. Neuro. Endocrinol. Lett., 27, 609-613.
43. Tsou, J.A. et al. (2007) Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma. Mol. Cancer., 6, 70.
44. Chen, H. et al. (2007) Loss of OPCML expression and the correlation with CpG island methylation and LOH in ovarian serous carcinoma. Eur. J. Gynaecol. Oncol., 28, 464-467.
45. Anglim, P.P. et al. (2008) Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer. Mol. Cancer., 7.
46. Cui, Y. et al. (2008) OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS ONE, 3, e2990.
47. Chang, E. et al. (2010) Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients. Hepatogastroenterology, 57, 720-727.
48. Ausch, C. et al. (2009) Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA. Clin. Chem., 55, 1559-1563.
49. Kim, J.H. et al. (2009) Comparative analysis of DNA methylation between primary and metastatic gastric carcinoma. Oncol. Rep., 21, 1251-1259.
50. Yu, J. et al. (2007) A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin. Cancer Res., 13, 7296-7304.
51. Popp, C. et al. (2010) Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature, 463, 1101-1105.
52. Lane, N. et al. (2003) Resistance of IAPs to methylation reprogramming may provide a mechanism for epigenetic inheritance in the mouse. Genesis, 35, 88-93.
53. Hajkova, P. et al. (2002) Epigenetic reprogramming in mouse primordial germ cells. Mech. Dev., 117, 15-23.
54. Liang, G. et al. (2002) Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell. Biol., 22, 480-491.
55. Hezel, A.F. et al. (2006) Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev., 20, 1218-1249.
56. Schmid, R.M. (2002) Acinar-to-ductal metaplasia in pancreatic cancer development. J. Clin. Invest., 109, 1403-1404.
57. Longnecker, D.S. et al. (1980) Focal acinar cell dysplasia in human pancreas. Cancer, 45, 534-540.
58. Kumagai, T. et al. (2007) Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells. Int. J. Cancer., 121, 656-665.